<?xml version="1.0"?>
<Articles JournalTitle="Journal of Biostatistics and Epidemiology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Journal of Biostatistics and Epidemiology</JournalTitle>
      <Issn>2383-4196</Issn>
      <Volume>6</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2020</Year>
        <Month>12</Month>
        <Day>31</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Risk Factors Associated with Lost to Follow up Among Multidrug Resistance Tuberculosis Patients Registered for Treatment in Programmatic Management of Drug Resistant Tuberculosis Sites of Punjab, Pakistan</title>
    <FirstPage>162</FirstPage>
    <LastPage>169</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Shamsa</FirstName>
        <LastName>Kanwal</LastName>
        <affiliation locale="en_US">National College of Business Administration &amp; Economics, Lahore, Pakistan</affiliation>
      </Author>
      <Author>
        <FirstName>Abdul</FirstName>
        <LastName>Akhtar</LastName>
        <affiliation locale="en_US">Indus Hospital Karachi, Lahore, Pakistan</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2020</Year>
        <Month>06</Month>
        <Day>17</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2020</Year>
        <Month>09</Month>
        <Day>12</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Introduction: Pakistan, a country with a 27 high burden countries of multidrug resistance tuberculosis. To predict the associated risk factors and proportion of loss to follow up among MDR-TB patients treated at PMDT sites of Punjab from 2017 to 2019.
Methodology: This case control study based on the standardized reporting and recording case record forms called as Electronic Nominal Review System (ENRS) of National TB Control Program, Pakistan. A logistic regression model was used to assess risk factors of lost to follow up MDR-TB patients.
Results: A total of 539 patients with MDR-TB were included in the final analysis. Among them, 207 patients (7.5%) had lost to follow up outcome at the end of the study. MDR-TB lost to follow up patients were more likely to report older age (AOR: 1.40, CI: 1.14-1.71, p=0.000),&#xA0; history of lost to follow up from first line drugs treatment (AOR: 0.39, CI: 0.28-0.56, p=0.000), co-morbid (AOR:1.54, CI: 1.24-1.91, p=0.000), adverse reaction of second line drugs (AOR: 0.45, CI: 0.37-0.56, p=0.000), long distance between patient&#x2019;s home and PMDT site (AOR: 0.68, CI: 0.52-0.89, p=0.001).
Conclusion: The history of lost to follow up from first line drugs treatment, co-morbid, older age and long distance were independent risk factors of MDR-TB. Proper training for PMDT sites staff, friendly follow up services and psychological counseling may help to reduce lost to follow up.</abstract>
    <web_url>https://jbe.tums.ac.ir/index.php/jbe/article/view/344</web_url>
  </Article>
</Articles>
